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Primary care
Screening older people for impaired vision in primary care:
cluster randomised trial
Liam Smeeth, Astrid E Fletcher, Smita Hanciles, Jennifer Evans, Richard Wormald
Abstract
Objective To determine the effectiveness of screening
for visual impairment in people aged 75 or over as
part of a multidimensional screening programme.
Design Cluster randomised trial.
Setting General practices in the United Kingdom
participating in the MRC trial of assessment and
management of older people in the community.
Participants 4340 people aged 75 years or over
randomly sampled from 20 general practices,
excluding people resident in hospitals or nursing
homes.
Intervention Visual acuity testing and referral to eye
services for people with visual impairment. Universal
screening (assessment and visual acuity testing) was
compared with targeted screening, in which only
participants with a range of health related problems
were offered an assessment that included acuity
screening.
Main outcome measures Proportion of people with
visual acuity less than 6/18 in either eye; mean
composite score of 25 item version of the National
Eye Institute visual function questionnaire.
Results Three to five years after screening, the relative
risk of having visual acuity < 6/18 in either eye,
comparing universal with targeted screening, was 1.07
(95% confidence interval 0.84 to 1.36; P = 0.58). The
mean composite score of the visual function
questionnaire was 85.6 in the targeted screening
group and 86.0 in the universal group (difference 0.4,
95% confidence interval − 1.7 to 2.5, P = 0.69).
Conclusions Including a vision screening component
by a practice nurse in a pragmatic trial of
multidimensional screening for older people did not
lead to improved visual outcomes.
Introduction
In population based surveys undertaken in the United
Kingdom, visual acuity of less than 6/12 (below the
United Kingdom driving requirement) has been found
in around 20% of people aged 75 or older.1–3 A recent
survey estimated that more than 70% of visual impair-
ment in people aged 65 or older was potentially reme-
diable.4 Visual impairment is associated with reduced
functional status and quality of life,5 low social contact,6
depression,7 and falls and hip fractures.8 It is therefore
unsurprising that primary care based screening of
older people for visual impairment has repeatedly
been called for.9–12
In practice, screening for visual impairment is likely
to be only one part of a multidimensional assessment.
Since 1990 in the United Kingdom the primary care
team has been required to offer an annual screening,
including an assessment of vision, to all patients aged
75 or over.13 Screening for visual problems is
specifically included in the single assessment process
to be offered to all older people proposed in the
national service framework for older people.14 How-
ever, the effectiveness of screening older people for
visual impairment has not been established. A system-
atic review in 1998 of the five trials to date found no
evidence that screening reduced the prevalence of
visual impairment.15 16 The lack of effectiveness in those
trials may have been due to the use of self reported
measures of vision as a screening instrument and the
lack of clear plans of intervention for the problems that
were identified.
To assess the effectiveness of screening for visual
impairment, we measured visual outcomes among a
random sample of participants in each arm of the
MRC trial of the assessment and management of older
people in the community.
Methods
The MRC trial of the assessment and management of
older people in the community is a community based
cluster randomised trial comparing different methods
of multidimensional screening in people aged 75 years
or over; it is taking place in 106 general practices from
the Medical Research Council’s general practice
research framework.3 17 18 People aged 75 years or over
who were registered with participating general
practices were included in the study unless they were
resident in a long stay hospital or nursing home or
were terminally ill.
Baseline screening occurred between 1995 and
1999. Practices were randomised to two forms of
screening: targeted or universal. Randomisation was
performed centrally at the London School of Hygiene
and Tropical Medicine, using a computer generated
randomisation list stratified by thirds of Jarman score
and of standardised mortality ratio. Because of the
nature of the intervention, participants or researchers
could not be blinded to the group assignment.
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Interventions
Universal screening group
All participants in the trial were invited to complete a
brief assessment followed by a detailed health
assessment by a trained nurse that included measure-
ment of visual acuity. Acuity was measured using a
Glasgow acuity chart, which measures vision on the
logMAR scale.19 For ease of interpretation, we give the
Snellen equivalent acuity. Binocular vision was
measured first, followed by vision in each eye.
Measurements were repeated in people with visual
acuity less than 6/18 in either eye, using a pinhole
occluder to provide an estimate of acuity corrected for
refractive error.20
For people with a pinhole vision of less than 6/18
in either eye, referral to an ophthalmologist was
recommended unless they had been seen by an
ophthalmologist in the previous year, or were
registered blind or partially sighted. People with
presenting vision of less than 6/18 in either eye that
improved with pinhole to better than 6/18 were
advised to see an optician. People with visual acuity less
than 6/18 who could not complete a pinhole
assessment were recommended for referral to an
ophthalmologist.
Targeted screening group
At the time the trial was started, the contractual obliga-
tion on general practitioners to offer all patients aged
over 75 years an annual health assessment meant it was
not possible to have a control group that was offered
no screening. In practices randomised to the targeted
screening strategy, participants were invited to
complete a brief screening assessment.17 This assess-
ment covered all areas specified in the general
practitioner contract, including a question about
difficulty seeing, but did not include measurement of
visual acuity. Only people found to have a specified
range and level of problems during the brief
assessment were invited to have a detailed assessment.
Although reporting a lot of difficulty seeing was one
possible factor contributing to eligibility for a more
detailed assessment, it was not on its own sufficient to
lead to an offer of a detailed assessment. The trial was
designed such that about 20% of people in the targeted
group would be eligible for a more detailed
assessment.
Sampling
We randomly sampled 10 practices from each arm of
the trial and 220 participants from each sampled prac-
tice and asked them to participate in the collection of
visual outcomes (fig 1).
At baseline the prevalence of visual acuity < 6/18
in one or both eyes was 30% with an intracluster corre-
lation coefficient of 0.022. We estimated that outcome
data for 2000 participants would provide over 80%
power significant at the 5% level to detect a 30% differ-
ence in the prevalence of visual impairment. To allow
for deaths and other losses to follow up we randomly
sampled 220 eligible participants from each practice.
Two practices in the universal screening group had
fewer than 220 eligible people: 170 in one practice and
210 in the other. The final sample therefore included
2140 people in the universal screening group and
2200 people in the targeted screening group.
Outcome assessment
Three to five years after the baseline screening,
sampled participants in the 20 practices included were
invited to have an assessment of their vision. Research
nurses assessed visual acuity and visual function and
asked participants about contact with any eye services.
In addition they searched medical records for
information relating to vision. The two primary
outcomes were the proportion of people with present-
ing visual acuity < 6/18 in one or both eyes, and the
composite score of the 25 item version of the National
Eye Institute visual function questionnaire. The
questionnaire has been shown to be a reliable and valid
measure of visual function;21 22 the highest available
score is 100 representing no disability related to vision.
Analysis
All analyses used the “survey” commands in Stata 7.0
and took account of the cluster design. The intention
to treat principle was applied as far as possible. Partici-
pants with outcome data available were analysed in the
group to which they were randomised, regardless of
whether they actually had a screening assessment at
baseline.23
Results
Response rates and baseline characteristics
In the targeted screening group, 76.5% (1684/2200) of
participants completed a brief screening assessment;
150 (6.8%) had sufficient number or severity of
problems to be eligible for a more detailed assessment
including visual acuity; and 120 (5.5%) completed the
detailed assessment. In the universal screening group,
73.1% (1565/2140) completed a detailed assessment
including visual acuity (fig 2). Table 1 shows the charac-
teristics of participants at baseline.
Vision screening and eligibility for referral
In the universal screening group, 451/1565 people
(28.8%) had a visual acuity < 6/18 in either eye. Of
these, 79 (18%) were eligible for referral to an optician
and 220 (49%) were eligible for referral to an ophthal-
mologist. Among the 120 people in the targeted
Total study group
106 general practices. All patients aged 75 (excluding
those in long term care or with terminal disease)
Randomisation
Targeted group
Intervention
53 practices. Participants offered
brief assessment, with detailed
assessment including visual
acuity for selected participants only
Intervention
53 practices. Participants
offered both brief and
detailed assessment,
including visual acuity test
Intervention group
Outcome
10 practices sampled,
total 2200 participants
Outcome
10 practices sampled,
total 2140 participants
About 220 patients sampled from each practice
Fig 1 Randomisation and sampling
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screening group who had a visual acuity test, the
proportion of people with reduced visual acuity was
higher than in the universal screening group (43% v
29%), as were the proportions eligible for referral to
the eye services (7% v 5% for referral to optician, 24% v
14% for referral to ophthalmologist) (table 2),
reflecting the fact that eligibility for vision screening
was based on having a specified level of problems
detected at the brief assessment.
Outcome assessment
A total of 1807 outcome assessments were completed,
90.4% of the target of 2000 (fig 2). Excluding the 1465
people who died before assessment of outcome, the
response rate was 62.8% (1807/2875). The response
rate was 5.7% lower in the universal screening group
(829/1432 v 978/1443), largely because two practices
in the universal screening arm had low response rates
because of problems with nurses’ workload. The
median time between baseline screening and outcome
assessment was 3.9 years (interquartile range 3.3-4.5
years) in the targeted screening group and 3.9 (3.4-4.3)
years in the universal group.
Primary outcomes
Comparing universal with targeted screening, we
found that the relative risk of visual acuity less than
6/18 in either eye was 1.07 (95% confidence interval
0.84 to 1.36; P = 0.58) (table 3). The mean composite
score of the National Eye Institute visual function
questionnaire was 85.6 in the targeted screening group
and 86.0 in the universal group, a difference of 0.4
( − 1.7 to 2.5; P = 0.69). The standard deviation for the
composite score was 17.8 overall and was similar in
both groups.
Adjustment for age, sex, level of self reported visual
difficulty at baseline, and time until follow up had no
impact on the results. Stratification by age, sex, level of
self reported visual difficulty at baseline, social
isolation, or time until follow up produced no evidence
of subgroup effects. For the subgroup with time to fol-
Randomisation
467 refused
37 no response
12 other*
* 4 too ill, 5 administrative error, 3 lost questionnaires
† 2 too ill, 2 administrative error, 1 lost questionnaire, 2 not invited
    (administrative error)
Targeted screening 2200
1684 had a brief
screening assessment
Universal screening 2140
120 had a detailed
assessment
978 completed outcome
assessment (includes 147 eligible
people randomised who did not
complete a baseline assessment)
Of all randomised:
757 died
266 refused
116 moved
59 too ill
24 not traced
829 completed outcome
assessment (includes 128 eligible
people randomised who did not
complete a baseline assessment)
Of all randomised:
708 died
404 refused
136 moved
53 too ill
10 not traced
498 refused
70 no response
7 other†
1565 had a detailed
assessment
Fig 2 Flow of participants through the study
Table 1 Baseline characteristics of participants. Values are percentages (numbers)
Targeted screening group (n=1684) Universal screening group (n=1662)
Men 36.8 (620) 39.8 (661)
Median age (years) 79.9 80.3
Reporting a lot of difficulty seeing newsprint 9.7 (162/1672) 7.7 (127/1668)
Socially isolated* 15.1 (254/1657) 16.8 (279/1666)
Reporting often or always having difficulty making ends meet 2.1 (35/1672) 2.3 (39/1669)
Reporting one or more falls at home in the previous six months 17.7 (290/1665) 20.4 (334/1636)
Taking 5 or more drugs regularly 17.6 (278/1602) 18.5 (286/1547)
*Defined as reporting seeing friends, neighbours, or relatives less than twice a week.
Table 2 Screening findings and eligibility for referral in people who had visual acuity screening. Values are percentages (numbers)
Findings Targeted screening (n=120) Universal screening (n=1565)
Detailed assessment
Visual acuity <6/18 in either eye 43 (53) 29 (451)
Pinhole assessment carried out 51 (27/53) 50 (223/451)
Visual acuity <6/18 in either eye that corrected to >6/18 with pinhole correction 6 (8) 50 (79)
Seen by ophthalmologist in previous 12 months 7 (8) 8 (130)
Registered:
Blind 3 (4) 1 (18)
Partially sighted 5 (6) 2 (35)
Data on registration status missing 3 (3) 1 (24)
Eligible for referral to optician 7 (8) 5 (79)
Eligible for referral to ophthalmologist 24 (29) 14 (220)
Other visual findings
Visual acuity <6/18 binocular 22 (26)* 12 (179)†
Visual acuity <6/12 in either eye 60 (72) 47 (736)
Visual acuity <6/12 binocular 46 (54)* 34 (508)†
Owned glasses 88 (105) 88 (1382)
*Excluding two people with missing data.
†Excluding 84 people with missing data.
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low up of 1.6 to 2.9 years, the relative risk of visual acu-
ity less than 6/18 in either eye was 1.06, compared with
1.07 for follow up of 3.0 to 3.9 years and 1.09 for follow
up of 3.9 to 5.8 years.
Restricting the analysis to people who had
completed their allocated baseline screening assess-
ments made little difference to the results. The relative
risk of visual acuity < 6/18 in either eye on universal
compared with targeted screening was 1.08 and differ-
ence in the mean composite score on the National Eye
Institute visual function questionnaire (universal arm
minus targeted arm) was 0.33 (86.1 in the targeted
group and 86.4 in the universal group, difference 0.3
( − 2.1 to 2.8, P = 0.78)).
Causes of visual impairment
Of the 504 people with visual acuity < 6/18 in either
eye, 87 (17.3%) had a pinhole corrected acuity > 6/18,
suggesting that the reduced vision could be attributed
at least partly to refractive error (table 2). Because
many people with reduced acuity did not complete a
pinhole assessment the proportion attributable to
refractive error will have been underestimated. The
nurses reported that many participants found the pin-
hole occluder difficult to use or said they could not see
properly through it.
Among the 249 people eligible for referral to an
ophthalmologist after the baseline assessment, we
obtained sufficient data to ascertain the likely causes of
the visual loss for 113. Of these, 28 (25%) had age
related macular degeneration, 59 (52%) had cataract
(of whom 19 had no record of previous extraction),
and 14 (12%) had both cataract and age related macu-
lar degeneration. Of the remaining 12, nine had a
range of various diagnoses and three had never been
seen by the eye services.
Referral to optician
The proportion of people advised to see an optician
who reported attending an optician at least once after
the baseline screening was high at 80% (32 out of 40
patients for whom data were available). New glasses or
lenses had been recommended for 24 people and had
been obtained by 18.
Referral to ophthalmologist
We obtained data for 75 people who had been eligible
for referral to an ophthalmologist after baseline
screening. There was clear evidence of a new referral
for only 55% (41) of those eligible for referral. The
proportion of people eligible for referral who were
referred varied by practice, from 12% to 100%. Among
the 41 people referred, uptake was high at 88% (36
patients), and 16 of these 36 people had a subsequent
cataract extraction.
Discussion
Even though this trial overcame possible reasons for
the lack of effectiveness of screening seen in previous
trials (by using measured visual acuity rather than self
reported problems, and by having a clear protocol for
intervention), it showed that screening older people for
visual impairment as part of a multidimensional
screening assessment gave no benefit
Possible explanations for lack of effect
A “no screening” control arm was not possible, but this
feature of the design is unlikely to explain the lack of
effect: in the targeted screening group, only 2.2% of
people were eligible for referral to the eye services,
compared with 18.0% in the universal screening group.
Although a high prevalence of visual impairment
was identified at screening, many affected people were
already in contact with the eye services. In addition, the
period between screening and assessment of outcome
was quite long (median 3.9 years). Improvement or
deterioration in vision between screening and follow
up could have been missed. The intervention was, how-
ever, no more effective in a subgroup with a shorter
time to assessment (1.6 to 3 years).
Response to outcome assessments seems low
because just over a third of participants had died by the
time of the assessment. The proportions who died
were similar in the two groups. The follow up rate was
5.7% lower in the universal screening group. Although
loss to follow up was not associated with baseline
vision, a small effect on the results of the trial cannot be
excluded.
Around half the people who had been advised to
see an optician obtained new lenses. However,
uncorrected refractive error was underdetected
because a minority of participants completed the pin-
hole assessment, largely because of difficulties with
using a pinhole occluder. Only 52% of people eligible
for a referral had evidence of a new referral to an oph-
thalmologist; in previous trials of multidimensional
screening, rates of clinicians’ adherence to recommen-
dations for referral have been in the range of 49% to
79%.24 Attendance at clinic of patients with evidence of
a new referral to an ophthalmologist was 88%, higher
than the range observed in previous trials (46% to
76%).24
Conclusion
Some people obtained beneficial interventions from
vision screening, but the number of people benefiting
was small in the context of a population based screen-
ing programme and was not sufficient to affect the
prevalence of visual impairment overall. The evidence
from randomised controlled trials undertaken to date
does not support the inclusion of a vision screening
component in multidimensional screening pro-
grammes for older people in a community setting.16
Table 3 Visual acuity outcomes. Values are percentages (numbers)
Targeted screening group(n=
978)
Universal screening
group(n=829) Risk ratio (95% CI) P value
Visual acuity <6/18 in either eye 34.7 (339/978) 37.0 (307/829) 1.07 (0.84 to 1.36) 0.58
Visual acuity <6/18 binocular vision 16.6 (160/962) 14.0 (114/817) 0.84 (0.64 to 1.10) 0.20
Visual acuity <6/12 in either eye 59.7 (584/978) 58.6 (486/829) 0.98 (0.82 to 1.17) 0.83
Visual acuity <6/12 binocular vision 36.5 (351/962) 31.3 (256/817) 0.86 (0.65 to 1.13) 0.27
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The recommendation that an assessment of vision be
included in the single assessment process proposed in
the national service framework for older people is not
supported by the evidence. Given the importance of
visual impairment among older people, other
strategies to improve their vision is needed. The effec-
tiveness of an optimised primary care based screening
intervention that overcomes possible factors contribut-
ing to the observed lack of benefit in trials to date war-
rants assessment.
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What is already known on this subject
Visual impairment is common and disabling and
can often be improved with treatment
A previous systematic review found no evidence to
support screening older people for visual
impairment
The trials used self reported measures of vision as
a screening instrument and lacked clear plans of
intervention for visual problems identified
What this study adds
This randomised trial overcame the possible
drawbacks of previous trials
Although a small number of people obtained
beneficial interventions as a result of screening,
this was not sufficient to reduce the prevalence of
visual impairment at the population level
Barriers to improving vision among older people
will need to be overcome before screening is likely
to be effective
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